Plaquenil maculopathy is a rare, but visually debilitating complication of using hydroxychloroquine medication. This course details utilizing special testing including Visual Fields and OCT for diagnosis. The 2011 and 2016 American Academy of Ophthalmology management recommendations including treatment and follow-up will be discussed, including what height, weight, and dosage constitutes high risk. New information about risk modification will help the optometrist manage patients on Plaquenil.

Course Code:



Anthony DeWilde, O.D.



AOA Expiration Date:


Related News

'All the advocacy firepower’ called up at AOA on Capitol Hill

Over 500 AOA doctors and optometry students championed the profession’s priority issues in Washington, D.C., including a growing Congressional focus on vision plan abuses.

Build your practice and protect the planet

Every day is Earth Day at these optometric practices. Considerations for an environmentally friendly practice.

Intentional leadership

The AOA’s 2023 Young Optometrist of the Year is a leader—and she has been intentional in cultivating those skills. Uncover her philosophy on leadership.